RankingsPricing
  1. US-listed companies
  2. TEVA PHARMACEUTICAL INDUSTRIES LTD
  3. Financials
  4. Return on Assets

TEVA PHARMACEUTICAL INDUSTRIES LTD【TEVA】

Market cap
$36.7B
P/E ratio
SummaryFinancials
Period EndReturn on Assets (Million USD)YoY (%)
Dec 31, 2024-4+209.37%
Dec 31, 2023-1.3-75.05%
Dec 31, 2022-5.1-651.61%
Dec 31, 20210.9-112.60%
Dec 31, 2020-7.4+336.69%
Dec 31, 2019-1.7-48.32%
Dec 31, 2018-3.3-83.57%
Dec 31, 2017-19.9-4522.22%
Dec 31, 20160.5-85.80%
Dec 31, 20153.2-51.23%
Dec 31, 20146.5+150.97%
Dec 31, 20132.6-33.59%
Dec 31, 20123.9-37.80%
Dec 31, 20116.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)